Although tumor-infiltrating CD8+ T cells have been reported to play an important role in PD-1 blockade–mediated antitumor immune response (2, 3, 15, 16), not all such T cells attack tumor cells, containing nonspecific bystander T cells (17, 18). This evidence concerns the gene CD8A and neoplasm.